3 data and information 3 - update

Update: Post 1.
The purpose of this thread is to collect any worthwhile data on PBT from the threads and sites and this will facilitate perusal by Investors.
Web site: http://www.pranabio.com/

1. Financial: PBT had a placement on 4 Sept, 2003; it now has $7 mill. cash.

Collaboration with Schering A G:
http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=202343

Comment: Options will supply about $10 mill. on 1 Dec. 2004-See below. Perhaps another deal will be made as well. I believe that no further capital raising is needed for quite some time, possibly 2 years or more.

2. Capital: Shares: 73.4 mill.
Options: 20.1 mill to pay 50 cents on 1 Dec. 2004 (PBTAK)
200,000 to pay 50 cents on 20/3/2004 (PBTAM)
410,000 to pay 50 cents on 30/6/2005 (PBTAO)
200, 000 to pay 50 cents on 1/10/2005 (PBTAQ)

3. Listings: Australia: "PBT " and Nasdaq: "PRAN" Every Nasdaq share or ADR has 10 PBT shares Quotation: http://quotes.nasdaq.com/quote.dll?mode=stock&kind=&symbol=NVGN&symbol=LOOK&symbol=PRAN&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&symbol=&FormType=&mkttype=&pathname=&page=quick&selected=PRAN

Currency conversion: http://www.xe.com/ucc/

4. Board: Experience and the Scientific Advisory Board:
http://www.pranabio.com/company_profile/

Research Facilities: University of Melbourne: http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=202080

Massachusetts General Hospital: http://stocknessmonster.com/news-item?S=PBT&E=ASX&N=180416

The Mental Health Research Institute of Victoria; Melbourne Australia
The Harvard Medical School.

5. Business: "The mission of Prana Biotechnology is to develop therapeutic drugs to treat the central disease pathways that cause degeneration of the brain and the eye as we age". Alzheimer's and Parkinson'd diseases are just two of the diseases PBT is interested in but at the moment research centres on Alzheimers:
http://www.pranabio.com/research/research_program.asp

Gerry
Please do your own research and you decide if and when to buy, hold or sell.